CCA
GILD icon

Childress Capital Advisors’s Gilead Sciences GILD Stock Holding History

Childress Capital Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.17M Sell
15,569
-367
-2% -$51.4K 0.39% 42
2025
Q4 		$1.96M Buy
15,936
+3,172
+25% +$385K 0.31% 51
2025
Q3 		$1.42M Buy
12,764
+5,190
+69% +$590K 0.26% 63
2025
Q2 		$840K Buy
7,574
+1,914
+34% +$204K 0.21% 77
2025
Q1 		$634K Buy
5,660
+112
+2% +$11.6K 0.18% 80
2024
Q4 		$512K Buy
5,548
+79
+1% +$7.11K 0.14% 99
2024
Q3 		$459K Sell
5,469
-292
-5% -$22.3K 0.12% 122
2024
Q2 		$395K Buy
5,761
+1,507
+35% +$101K 0.11% 125
2024
Q1 		$312K Sell
4,254
-865
-17% -$66.5K 0.09% 145
2023
Q4 		$415K Buy
5,119
+1,077
+27% +$83.8K 0.12% 106
2023
Q3 		$303K Buy
+4,042
New +$311K 0.1% 122
2023
Q1 		– Sell
-5,155
Closed -$443K – 121
2022
Q4 		$443K Sell
5,155
-856
-14% -$67.8K 0.15% 103
2022
Q3 		$375K Buy
6,011
+1,940
+48% +$122K 0.15% 101
2022
Q2 		$252K Buy
4,071
+259
+7% +$16K 0.1% 136
2022
Q1 		$226K Sell
3,812
-1,089
-22% -$69.6K 0.08% 169
2021
Q4 		$356K Sell
4,901
-1,383
-22% -$95.3K 0.15% 116
2021
Q3 		$438K Buy
6,284
+2,943
+88% +$207K 0.18% 104
2021
Q2 		$230K Sell
3,341
-2,584
-44% -$173K 0.1% 145
2021
Q1 		$382K Buy
5,925
+1,668
+39% +$108K 0.18% 109
2020
Q4 		$248K Buy
+4,257
New +$257K 0.14% 82

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Childress Capital Advisors's GILD Position: Q1 2026 in Review

Childress Capital Advisors reduced its Gilead Sciences (GILD) stake by 2.3% in Q1 2026, selling an estimated $51.4K and leaving 15,569 shares worth $2.17M. The position accounts for 0.39% of the portfolio, ranked #42.

Childress Capital Advisors first reported a position in GILD in Q4 2020 and has held it in 20 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Childress Capital Advisors held 15,569 shares of Gilead Sciences worth $2.17M as of Q1 2026.
  • Childress Capital Advisors sold 367 Gilead Sciences shares in Q1 2026, an estimated $51.4K.
  • Gilead Sciences made up 0.39% of Childress Capital Advisors's portfolio in Q1 2026, its #42 holding.
  • Childress Capital Advisors first reported a position in Gilead Sciences in Q4 2020 and has held it in 20 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Childress Capital Advisors's 13F filing for Q1 2026, filed 29 Apr 2026.